$4.39
1.62% today
Nasdaq, Nov 13, 07:07 pm CET
ISIN
CH1125843347
Symbol
SOPH

SOPHiA Genetics SA Stock price

$4.32
+0.28 6.93% 1M
+1.14 35.64% 6M
+1.25 40.72% YTD
+0.33 8.27% 1Y
+2.28 111.76% 3Y
-12.44 74.22% 5Y
-12.44 74.22% 10Y
-12.44 74.22% 20Y
Nasdaq, Closing price Wed, Nov 12 2025
-0.30 6.49%
ISIN
CH1125843347
Symbol
SOPH

Key metrics

Basic
Market capitalization
$291.9m
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative | negative
P/S
4.0 | 3.8
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
62.1%
Return on Equity
-64.8%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$73.3m | $76.0m
EBITDA
$-59.4m | $-40.2m
EBIT
$-68.8m | $-67.6m
Net Income
$-75.0m | -
Free Cash Flow
$-46.5m
Growth (TTM | estimate)
Revenue
13.7% | 16.6%
EBITDA
0.6% | 30.7%
EBIT
-1.0% | -1.6%
Net Income
-5.0% | -
Free Cash Flow
10.7%
Margin (TTM | estimate)
Gross
67.5%
EBITDA
-81.1% | -52.9%
EBIT
-93.8%
Net
-102.3% | -
Free Cash Flow
-63.4%
More
EPS
$-1.1
FCF per Share
-
Short interest
0.3%
Employees
423
Rev per Employee
$150.0k
Show more

Is SOPHiA Genetics SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

SOPHiA Genetics SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a SOPHiA Genetics SA forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a SOPHiA Genetics SA forecast:

Buy
90%
Hold
10%

Financial data from SOPHiA Genetics SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
73 73
14% 14%
100%
- Direct Costs 24 24
15% 15%
32%
49 49
13% 13%
68%
- Selling and Administrative Expenses 84 84
8% 8%
114%
- Research and Development Expense 35 35
0% 0%
48%
-59 -59
1% 1%
-81%
- Depreciation and Amortization 9.38 9.38
13% 13%
13%
EBIT (Operating Income) EBIT -69 -69
1% 1%
-94%
Net Profit -75 -75
5% 5%
-102%

In millions USD.

Don't miss a Thing! We will send you all news about SOPHiA Genetics SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SOPHiA Genetics SA Stock News

Neutral
PRNewsWire
2 days ago
BOSTON , Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precisio...
Neutral
PRNewsWire
2 days ago
BOSTON and SAN DIEGO , Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline g...
Neutral
Seeking Alpha
9 days ago
SOPHiA GENETICS SA ( SOPH ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Kellen Sanger - Head of Strategy and Investor Relations Jurgi Camblong - Co-Founder, CEO & Director Ross Muken - President George Cardoza - Executive VP & CFO Conference Call Participants William Bonello - Craig-Hallum Capital Group LLC, Research Division Subhalaxmi Nambi - Guggenheim Securities,...
More SOPHiA Genetics SA News

Company Profile

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Head office Switzerland
CEO Jurgi Camblong
Employees 423
Founded 2011
Website www.sophiagenetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today